Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul:171:111370.
doi: 10.1016/j.jclinepi.2024.111370. Epub 2024 Apr 24.

Common challenges and suggestions for risk of bias tool development: a systematic review of methodological studies

Affiliations
Free article

Common challenges and suggestions for risk of bias tool development: a systematic review of methodological studies

Eve Tomlinson et al. J Clin Epidemiol. 2024 Jul.
Free article

Abstract

Objectives: To review the findings of studies that have evaluated the design and/or usability of key risk of bias (RoB) tools for the assessment of RoB in primary studies, as categorized by the Library of Assessment Tools and InsTruments Used to assess Data validity in Evidence Synthesis Network (a searchable library of RoB tools for evidence synthesis): Prediction model Risk Of Bias ASessment Tool (PROBAST) , Risk of Bias-2 (RoB2), Risk Of Bias In Non-randomised Studies of Interventions (ROBINS-I), Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2), Quality Assessment of Diagnostic Accuracy Studies-Comparative (QUADAS-C), Quality Assessment of Prognostic Accuracy Studies (QUAPAS), Risk Of Bias in Non-randomised Studies of Exposures (ROBINS-E), and the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) RoB checklist.

Study design and setting: Systematic review of methodological studies. We conducted a forward citation search from the primary report of each tool, to identify primary studies that aimed to evaluate the design and/or usability of the tool. Two reviewers assessed studies for inclusion. We extracted tool features into Microsoft Word and used NVivo for document analysis, comprising a mix of deductive and inductive approaches. We summarized findings within each tool and explored common findings across tools.

Results: We identified 13 tool evaluations meeting our inclusion criteria: PROBAST (3), RoB2 (3), ROBINS-I (4), and QUADAS-2 (3). We identified no evaluations for the other tools. Evaluations varied in clinical topic area, methodology, approach to bias assessment, and tool user background. Some had limitations affecting generalizability. We identified common findings across tools for 6/14 themes: (1) challenging items (eg, RoB2/ROBINS-I "deviations from intended interventions" domain), (2) overall RoB judgment (concerns with overall risk calculation in PROBAST/ROBINS-I), (3) tool usability (concerns about complexity), (4) time to complete tool (varying demands on time, eg, depending on number of outcomes assessed), (5) user agreement (varied across tools), and (6) recommendations for future use (eg, piloting) and development (add intermediate domain answer to QUADAS-2/PROBAST; provide clearer guidance for all tools). Of the other eight themes, seven only had findings for the QUADAS-2 tool, limiting comparison across tools, and one ("reorganization of questions") had no findings.

Conclusion: Evaluations of key RoB tools have posited common challenges and recommendations for tool use and development. These findings may be helpful to people who use or develop RoB tools. Guidance is necessary to support the design and implementation of future RoB tool evaluations.

Keywords: Evaluation; Quality assessment; Research methods; Risk of bias; RoB; Systematic reviews.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Eve Tomlinson: Since working on this review, Eve has joined the QUADAS-3 steering group. Chris Cooper: None. Clare Davenport: Clare Davenport is a member of the Diagnostic test Accuracy Editorial Team and is an author on the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Studies. Clare was a member of the QUADAS-2 working group and a member of the QUADAS-C steering group. She is currently a member of the QUADAS-3 steering group. Anne W.S. Rutjes: Anne is regularly hired by the Federal office of Public Health in Bern, Switzerland as a methodological consultant for Health Technology Assessment reports and receives teaching fees from the academic sector on topics related to research designs, risk of bias tools, and reporting tools. Anne was an editor for the Cochrane Dementia and Cognitive Improvement group up to March 2023 and is an author on the Cochrane Handbook for Systematic Reviews on Diagnostic Test Accuracy Studies. She was a panel member of PROBAST and various COSMIN tools, part of the steering group of QUADAS and QUADAS-2, is part of the core group developing a RoB tool for prevalence studies, and one developing a RoB and reporting tool for use in studies evaluating the incidence of adverse events detected with record review methods. Mariska Leeflang: Mariska Leeflang is an author of the following risk of bias tools: QUADAS-C, QUADAS-2, and PROBAST. Mariska is an editor of the Cochrane Diagnostic Test Accuracy Handbook. Sue Mallett: Sue Mallett is an author of the following risk of bias tools: QUADAS-C, QUADAS-2, and PROBAST. She is also on the leadership board for the LATITUDES Network. No payments are associated with this. Penny Whiting: Penny is an author on the Cochrane Handbook for Systematic Reviews on Diagnostic Test Accuracy Studies. She led the development of QUADAS and QUADAS-2, and was a steering group member for the development of PROBAST. She contributed to the development of RoB 2 and ROBINS-I. She is also on the leadership board for the LATITUDES Network.

Similar articles

Cited by

Publication types

LinkOut - more resources